Abstract
Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have